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Lack of Evidence for
Chloramphenicol Resistance
in Neisseria meningitidis, Africa
To the Editor: High-level chloramphenicol
resistance has been reported in 11 epidemio-
logically unrelated Neisseria meningitidis
serogroup B strains in Vietnam and in a single
strain in France, all isolated between 1987 and
1996 (1). Resistance was mediated by a
chloramphenicol acetyltransferase (Cat) en-
coded by a catP gene homologous to
Clostridium perfringens transposon Tn4451.
While used infrequently in industrialized
countries, chloramphenicol is often used to
treat patients with meningococcal disease in
Africa, especially during epidemics, when it
frequently becomes the drug of choice because it
can be administrated intramuscularly (2).
To evaluate the presence of meningococcal
chloramphenicol-resistant isolates in Africa, we
assessed the frequency of the catP gene in 33
N. meningitidis strains of serogroup A from the
collection of the Centers for Disease Control
and Prevention’s Epidemic Investigations
Laboratory. The isolates, selected to give the
maximum geographic and chronological repre-
sentation, were collected during 1963 to 1998
from Chad, Egypt, Gambia, Ghana, Niger,
Nigeria, South Africa, Tanzania, and Uganda,
mostly during outbreaks. Thirteen (39.3%) of
the strains were isolated during the 1990s,
when chloramphenicol resistance was first
described in Vietnam. All isolates were charac-
terized by multilocus enzyme electrophoresis
and represented four major electrophoretic
subgroups (3,4). Chloramphenicol and penicillin
MICs were determined for all isolates, accord-
ing to the recommendations of the National
Committee for Clinical Laboratory Standards,
by the broth microdilution method using
Mueller-Hinton broth with 5% lysed horse blood
incubated in 5% CO2 (5). All isolates were
susceptible to both chloramphenicol (MIC
<2 µg/mL) and penicillin (MIC <0.06 µg/mL). In
addition, we tested all isolates for the presence
of catP by polymerase chain reaction (PCR)
using primers A, B, C, and D (1). Primers A and
B, designed from the sequence of catP, amplify
a 300-bp fragment only in chloramphenicol-
resistant isolates. Primers C and D, designed
on the basis of meningococcal sequences flank-
ing the Tn4451-like insertion, amplify ~1200-bp
fragment in resistant isolates and ~200-bp
fragment in susceptible strains. Strain
LNP13947 (kindly provided by Marc Galimand)
was used as a positive control.
The catP gene was not detected in 32 of 33
N. meningitidis serogroup A strains. One
isolate that was negative with primers C and D
tested positive with primers A and B (M2786,
Nigeria, 1963), which could suggest that catP
was present but in a different location in the
meningococcal genome. However, the chloram-
phenicol MIC of that strain was 2 µg/mL
(susceptible). Repeated attempts to sequence
the A/B amplicon were not successful with
either primers A and B or another set of prim-
ers internal to primers A and B, implying that
only a portion of the catP gene was present or
(even more likely, given the conserved nature
of this gene) that the PCR result was a false
positive.
Chloramphenicol resistance was first
described in meningococcal serogroup B isolates
(1), but only serogroup A strains were included
in this study since A is the most prevalent
serogroup in Africa. (It accounts for most
epidemics in Sub-Saharan regions.) Although
our small sample size limited the chances of
detecting a rare event, the data suggest that
chloramphenicol resistance in Africa is rela-
tively infrequent and that chloramphenicol is
still an appropriate agent to treat meningococ-
cal disease.
The acquisition of plasmids encoding Cat,
which enzymatically inactivate choramphenicol,
is the most common mechanism of resistance in
gram-positive and gram-negative organisms.164 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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The catP gene has been found on various
bacterial chromosomes and conjugative plas-
mids as part of the transposable element
Tn4451. This transposon is derivative of the
Tn6338 that contains six genes, the largest of
which, TnpX, is required for the excision of the
transposon in both Escherichia coli and
C. perfringens (6). The Tn4451 derivative that
lacked the functional TnpX gene was com-
pletely stable in both organisms because it had
lost mobility as a result of these internal
deletions (6). The finding of catP in
N. meningitidis within such a truncated
immobile transposon (1) and the possibility of
transfer of this type of resistance among highly
transformable organisms such as Neisseria spp.
are of great concern. Were the transposon to
become a stable part of the meningococcal
genome, it could potentially be easily ex-
changed. Interspecies recombination between
antibiotic-resistant genes of N. meningitidis
and commensal Neisseria spp. has occurred in
penicillin- and sulfonamide-resistant meningo-
cocci (7-10). A similar occurrence may be
possible for N. meningitidis chloramphenicol
resistance in Africa or other continents where
this antibiotic is routinely used for treatment of
patients with meningococcal diseases. Studies
have not yet demonstrated the clinical signifi-
cance of chloramphenicol resistance caused by
the catP gene in meningococci. However, it is
possible that, in developing countries, patients
whose illness does not respond to antimicrobial
agents may not be detected, or their isolates
may not be obtained. Screening a selection of
isolates for catP may allow early detection of
chloramphenicol-resistant strains. Since detec-
tion of increasing chloramphenicol resistance
could change recommendations for antimicro-
bial-drug therapy, surveillance for antimicro-
bial-drug resistance should be encouraged.
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Iron Loading and Disease Surveillance
To the Editor: We read with interest the article
by E. D. Weinberg entitled “Iron Loading and
Disease Surveillance” (1). Dr. Weinberg pro-
poses routine population screening of iron
values by serum ferritin and transferrin satura-
tion tests. Such screening could provide valu-
able information for epidemiologic, diagnostic,